Generalists and Specialists: A New View of How MHC Class I Molecules Fight Infectious Pathogens. by Kaufman, Jim
1  
Long title: Generalists and specialists: a new view of how MHC class I molecules 1 fight infectious pathogens 2  3 Jim Kaufman 4  5 University of Cambridge 6 Department of Pathology, Tennis Court Road, Cambridge, CB2 1QP, UK 7 Department of Veterinary Medicine, Madingley Road, Cambridge, CB2 0ES, UK 8  9 Correspondence: jfk31@cam.ac.uk (J. Kaufman) 10  11 Summary: 12  13 In comparison to the MHC of typical mammals, the chicken MHC is simple and 14 compact, with a single dominantly-expressed class I molecule that can determine 15 the immune response. In addition to providing useful information for the poultry 16 industry and allowing insights into the evolution of the adaptive immune system, 17 the simplicity of the chicken MHC has allowed discovery of phenomena that are 18 more difficult to discern in the more complicated mammalian systems. This 19 review discusses the new concept that poorly-expressed promiscuous class I 20 alleles act as generalists to protect from a wide variety of infectious pathogens, 21 while highly-expressed fastidious class I alleles can act as specialists to protect 22 against new and dangerous pathogens.   23 
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Insights from studying a simpler system 24   25 An enormous body of knowledge about the major histocompatibility complex 26 (MHC) and MHC molecules has been amassed over the last 50 years, mostly due 27 to work on humans and important biomedical model species like mice [1]. This 28 information is extremely detailed, complex but well-integrated, and crucially 29 important, both for basic scientific understanding of immune and autoimmune 30 responses, and for practical medical applications, including transplantation [2,3]. 31 What is the point of trying to understand the MHC in non-mammalian 32 vertebrates, when there is such rich and relevant knowledge for placental 33 mammals? 34  35 Besides the obvious importance to disease resistance and vaccination in poultry 36 [4,5], research into the chicken MHC has led to novel insights about the evolution 37 of the adaptive immune system [6-9]. This short review highlights a third 38 advantage: how the simplicity (at least in some senses) of the chicken MHC has 39 permitted discovery and/or study of phenomena that have been more difficult to 40 discern in complex MHC biology in humans and other typical mammals.  41  42 Resistance to infectious disease 43  44 It is generally accepted that the high level of allelic polymorphism of MHC class I 45 and class II genes is driven by a molecular arms race with pathogens [10,11]. An 46 expectation from this relationship is that particular MHC alleles would confer 47 resistance or susceptibility to particular infectious pathogens. The human MHC 48 
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does have many strong genetic associations with autoimmune disease, but the 49 reported associations with infectious disease are much weaker [2,12]. In 50 essence, it has taken the best immunologists, epidemiologists and geneticists 51 decades to provide convincing evidence for such genetic associations. The best-52 studied example is the slow progression of human immunodeficiency virus (HIV) 53 infection to acquired immunodeficiency syndrome (AIDS) conferred by the 54 presence of certain HLA-B alleles as well as cell surface expression levels of HLA-55 C alleles  [13,14]. 56  57 In contrast, already decades ago the poultry immunologists were stumbling over 58 extremely strong associations between the B blood group and resistance to a 59 variety of economically-important infectious diseases [15]. The MHC encoding 60 classical class I and class II molecules is one region (the so-called BF-BL region) 61 within this B locus [16]; nearby are regions with CD1 genes, TRIM genes and the 62 mysterious BG genes that have some similarities to butyrophilins [4,5]. Initially, 63 these associations were with responses to oncogenic viral diseases such as 64 Marek’s disease and Rous sarcoma, with the B locus determining life or death of 65 the individual chickens. Now there is a long list of viruses, bacteria and even 66 parasites that have significant associations with the BF-BL region [4,5,17,18]. 67  68 A minimal essential MHC with a single dominantly-expressed class I molecule 69  70 Compared to the MHC of typical mammals, the BF-BL region of chickens (also 71 sometimes called the “classical MHC” or the “core MHC”) is compact, simple and 72 arranged differently (Fig. 1), with two class II B (so-called BLB) genes flanking 73 
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the tapasin gene located near to the DM genes, followed by a pair of class I (so-74 called BF) genes that flank the TAP genes, and finally the class III region genes 75 [16]. Moreover, there has been no recombination within the BF-BL region 76 observed in experiments [19-22], although comparison of haplotypes shows that 77 there has been some recombination over unknown spans of time [23-25]. Also, 78 the genes involved in peptide loading (tapasin, TAP and DM) are all highly 79 polymorphic with each BF-BL haplotype generally having a unique set of alleles 80 [24,26-28]. The monomorphic DR-like class II A gene (BLA) is located some 5 cM 81 away [29], the monomorphic β2-microglobulin (β2m) gene is on a different 82 chromosome [30,31], and inducible proteasome (LMP/PSMB) genes have not 83 been found in the genome [32]. Thus, the polymorphic classical class I and class 84 II B genes are in strong linkage disequilibrium with polymorphic peptide-loading 85 genes, leading to relatively stable MHC haplotypes of polymorphic co-evolving 86 genes [33,34].  87  88 This co-evolution is clearly seen in the chicken class I system, in which the 89 specificity of peptide translocation by the TAP alleles correlates with the peptide 90 motif of the class I molecule encoded by the BF2 (but not the BF1) gene 91 [27,34,35]. Thus, the BF2 class I molecule receives lots of peptides whereas the 92 BF1 molecule gets far fewer peptides and might be expected to have become 93 much less important for antigen presentation. In fact, the BF1 gene has suffered 94 deletions and insertions leading to far less expression at the RNA and protein 95 levels than the BF2 gene [36]. Most importantly, the peptides presented by the 96 dominantly-expressed BF2 molecule can explain the immune response to certain 97 economically-important viruses and vaccines [37-39]. 98 
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 99 Such a system of co-evolving alleles is not found in most placental mammals. In 100 humans and other typical mammals, the antigen processing and peptide-loading 101 genes are located in the class II and extended class II regions, far away from the 102 class I genes that they serve [40]. Thus, alleles of antigen processing and peptide-103 loading genes that were advantageous for any particular class I allele would 104 relatively rapidly be switched by recombination [41], and any advantage lost. In 105 fact, there are few sequence alleles of TAP, tapasin and inducible proteasome 106 components, and these appear to be functionally monomorphic [42-44], working 107 as average best fits to provide peptides for all class I molecules, regardless of 108 locus or allele. This situation allows for a multigene family of class I genes, all of 109 which are (or can be, for HLA-C) relatively well-expressed. Just to be clear, there 110 are mammals (like rats) for which the classical class I genes have moved close to 111 the antigen processing and peptide-loading genes, with the result that one of the 112 TAP genes is oligomorphic and co-evolves with the class I molecule(s) [45].  113  114 The difference in the number of class I loci that encode well-expressed class I 115 molecules provides at least part of the explanation for the difference between 116 human and chicken MHC in genetic association with infectious disease [4,33]. In 117 humans, if one class I molecule doesn’t bind a protective peptide, it is likely that 118 another one will, so that overall, most MHC haplotypes confer more-or-less 119 resistance to most pathogens, which reads out as low genetic associations. In 120 chickens, the single dominantly-expressed class I molecule either finds a 121 protective peptide from a particular pathogen or it doesn’t, and this life-and-122 death difference between haplotypes reads out as strong genetic associations 123 
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(Fig. 2). Thus, the simplicity of the chicken MHC has allowed greater appreciation 124 of this phenomenon of resistance to infectious disease. 125  126 Evolution of the MHC 127  128 Why do chickens and typical mammals differ in the genomic organization of the 129 MHC, if the end result can be so dire for an individual chicken? The salient 130 features of the chicken MHC class I system can be found in many if not most non-131 mammalian vertebrates [6,10,46]. For example, ducks have polymorphic TAP 132 genes next to five class I genes, only one of which is expressed at a high level 133 [47,48]. Xenopus frogs have a single classical class I gene along with the TAP 134 (apparently at least oligomorphic) and tapasin genes located together, with this 135 class I region in between the class II region and the class III region [49]. Atlantic 136 salmon have a single classical class I gene close to the TAP2 gene, with this 137 region having a strong genetic association with resistance to at least one 138 economically-important virus [50,51].  139  140 The organization originally discovered for chickens is likely to be the ancestral 141 one. The genes for antigen processing, peptide loading and antigen presentation 142 are not closely-related, so they did not evolve by gene duplication and 143 acquisition of new functions. Instead, unrelated genes co-evolved to work 144 together as a pathway, and such co-evolution is favored by close linkage. In other 145 words, the genes of the class I system and by extension the class II system, T cell 146 receptors and natural killer (NK) cell receptors are likely to have emerged in one 147 region, a primordial MHC, which has been falling apart ever since [6,9]. In 148 
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support of this notion, genes found in various locations around the genome of 149 mammals are found in or near the MHC of non-mammalian vertebrates. For 150 example, the genes for an NK cell receptor and putative ligand (BNK and Blec, 151 like NKR-P1 and LLT1-clr) are found in the chicken MHC, rather than in the 152 region syntenic to the natural killer complex (NKC) as in mammals [16,52]. 153  154 Thus it is the mammalian MHC that is novel, and indeed the MHC of at least one 155 marsupial is organized like chickens [53], so that the change happened in the 156 lineage leading to placental mammals [6,9,27]. A potential mechanistic 157 explanation for this change would be an inversion (Fig. 3) that brought the class 158 III region into the center of the MHC and swung the class I gene(s) to the outside, 159 with the breakpoint such that the antigen processing and peptide loading genes 160 were left behind and eventually became part of the class II region. As discussed 161 above, sufficient levels of recombination meant that advantageous combinations 162 of genes could not stay together, and the TAP, tapasin and inducible proteasome 163 genes become average best fits for whatever class I allele appeared by 164 recombination. Once many alleles could be serviced, a multigene family became 165 possible.  166  167 Low-expressing promiscuous and high-expressing fastidious chicken class I 168 alleles 169  170 Some associations with the chicken MHC could be easily explained by the BF2 171 class I allele from a resistant (but not a susceptible) chicken finding a protective 172 peptide [37,39], but the very strong associations with Marek’s disease were 173 
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more challenging to explain. Marek’s disease virus (MDV), an oncogenic herpes 174 virus with a complex life cycle and significant evolution of virulence in historic 175 times, has been an enormous economic problem [54]. It wasn’t clear how the 176 MHC might confer susceptibility, since any class I molecule would be expected to 177 bind a protective peptide from at least one of the 100 MDV genes. However, MHC 178 haplotypes like B19 were strongly associated with susceptibility while B2 and 179 B21 were strongly associated with resistance [55].  180  181 It has become clear that the BF2 molecules from susceptible haplotypes have 182 peptide motifs much like typical mammalian class I molecules, with several 183 pockets in the binding groove, each one of which binds only one or a few similar 184 amino acids [37,56]. Such class I molecules might be called fastidious, with 185 stringent peptide motifs and narrow peptide repertoires. In contrast, the BF2 186 molecules from resistant haplotypes can bind an exceedingly large variety of 187 peptides and might be called promiscuous, with relaxed peptide motifs and wide 188 peptide repertoires [38,57]. For instance, the molecule BF2*021:01 remodels the 189 binding site to accommodate three anchor residues, at peptide positions P2, Pc-2 190 and Pc, with nearly every single amino acid found at P2 and Pc-2 [38,57]. Other 191 chicken class I molecules like BF2*02:01 and BF2*14:01 use broad binding 192 pockets capable of accommodating many amino acids with hydrophobic side 193 chains, which are particularly common in most proteins [57].  194  195 The correlation of peptide repertoire with resistance to Marek’s disease was 196 unexpected. One hypothesis to explain this correlation [57] is that the few MDV 197 peptides presented by fastidious molecules activate too few T cell clones to be 198 
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effective (as seems to be the case based on one study [58]), while the 199 promiscuous class I molecules provide a wide-ranging response involving many 200 T cell clones. Alternatively, the truly protective peptides might be so few in 201 number that the promiscuous BF2 molecules have a greater chance of presenting 202 such peptides.  203  204 Intriguingly, the fastidious class I molecules are found on the cell surface at a 205 high level, whereas the promiscuous molecules are expressed on the cell surface 206 at a lower level. This cell surface expression level is not dependent on the level of 207 transcription or translation, or on kinetics of translocation to the cell surface or 208 degradation. Overall, the population of highly-expressed fastidious molecules 209 shows greater thermal stability than the poorly-expressed promiscuous 210 molecules, although very stable complexes with particular peptides are found for 211 both kinds of molecules [37,38,56,57].  212  213 This inverse correlation of peptide repertoire with cell surface expression was 214 also unexpected. It seems most likely that the number of molecules arriving on 215 the cell surface is determined by the interaction of the particular TAP, tapasin 216 and BF2 alleles in the peptide-loading complex. The underlying reason for this 217 mechanism might just be the biochemistry of peptide loading, but alternatively 218 there could be evolutionary selection for the inverse correlation. One hypothesis 219 is that promiscuous BF2 molecules present so many self-peptides that negative 220 selection would deplete too many T cell clones in the thymus, and that reducing 221 the cell surface expression would reduce the extent of negative selection, with a 222 balance of peptide repertoire and cell surface expression resulting in an optimal 223 
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T cell repertoire [57]. Several other hypotheses can be imagined, including a 224 balance between the responses to pathogens for protection versus the 225 recognition of self that could lead to autoimmunity, or the balance between 226 antigen presentation for T cell recognition and a role as a ligand for NK cells.  227  228 An inverse correlation of cell surface expression and peptide repertoire for 229 human classical class I alleles 230  231 To what extents do these observations about class I molecules extend beyond 232 chickens? Obviously, the potential contributions of polymorphism in TAP and 233 tapasin cannot extend to mammals which have monomorphic antigen processing 234 and peptide loading genes. However, the linkages of peptide repertoire, cell 235 surface expression, translocation to the cell surface, stability and resistance to a 236 viral disease are found for human class I molecules. Striking differences were 237 reported in the predicted peptide repertoire of four HLA-B alleles that correlated 238 with the speed of progression from HIV infection to AIDS, with the fastidious 239 HLA-B*057:01 and HLA-B*027:05 alleles associated with long-term non-240 progression compared to the promiscuous HLA-B*07:02 and HLA-B*035:01 241 associated with rapid progression [59]. Subsequently, the cell surface expression 242 levels of these four HLA-B alleles were shown to vary inversely with peptide 243 repertoire, mirroring the findings in chickens [57]. Measurements of direct 244 peptide binding for 27 HLA-A and HLA-B alleles showed a wide range of peptide 245 repertoires [60]. An early immunoprecipitation study reported that one HLA-A 246 and six HLA-B alleles were mostly in a peptide-bound conformation, while seven 247 HLA-A and three HLA-B alleles were mostly bound to TAP molecules, suggesting 248 
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a range of peptide-loading efficiencies [61].  Assays with transfected cDNA clones 249 for 27 HLA-B alleles show that some alleles have a strong tapasin-dependence on 250 cell surface expression (tapasin-independent alleles generally being correlated 251 with faster HIV progression) [62], implicating dependence on translocation to 252 the cell surface as in chickens [35]. Although the data is not strictly comparable 253 between all these reports, wider peptide repertoire, lower cell surface 254 expression level, longer TAP binding, tapasin-independence of translocation and 255 faster HIV progression for HLA-A and HLA-B alleles seem to be broadly (but not 256 perfectly) correlated [63], with many (but not all) HLA-A molecules being more 257 promiscuous and many (but not all) HLA-B molecules being more fastidious. 258 Overall, the similarities between chickens and humans suggest that these are 259 fundamental properties of classical class I molecules.  260  261 However, there are clearly differences between the human and chicken class I 262 systems. The range of peptide binding for human class I alleles appears to be less 263 than that of chickens. For instance, HLA-A*02 molecules are the most 264 promiscuous human class I molecules, accommodating hydrophobic amino acids 265 that are very common in proteins, but only two or three different amino acids in 266 each pocket as opposed to the six different amino acids accommodated by the 267 highly promiscuous chicken BF2*002:01 [57,64,65]. Similarly, the very fastidious 268 HLA-B*57:01 only specifies amino acids for two pockets, one of which requires 269 the rare amino acid tryptophan, whereas the other pocket allows the very 270 common amino acids Ala, Ser and Thr. In contrast, the highly fastidious chicken 271 class I molecule BF2*004:01 requires binding of acidic amino acids in each of 272 three pockets [37,56,66]. Perhaps the presence of a multigene family of human 273 
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class I molecules means that the selective pressure for extremely promiscuous 274 and fastidious molecules is lower than in chickens.  275  276 A second difference might be that cell surface expression has been correlated 277 with tapasin-dependence in humans but thus far only with TAP specificity in 278 chickens; the effect of chicken tapasin has not been examined [35,62]. In any 279 case, human tapasin and TAP genes are functionally monomorphic, so any effect 280 in the peptide-loading complex would depend on the polymorphic positions in 281 the class I allele [42-44]. In contrast, chicken tapasin and TAPs genes are all 282 polymorphic, and appear to co-evolve with the dominantly-expressed class I BF2 283 gene [26,27], so the interactions could be more complex.  284  285 HLA-C presents a special challenge, perhaps because the relative importance of 286 various sequence features remains controversial. HLA-C molecules are found 287 expressed on the surface of most cells at a much lower level than HLA-A and 288 HLA-B (perhaps commensurate with a greater role for HLA-C as ligand for NK 289 cells rather than as an antigen presentation molecule for T cells) [67]. In 290 addition, HLA-C alleles vary in their cell surface expression (with higher 291 expression correlated with slower HIV progression, perhaps due to T cell 292 recognition) [68-70]. Various features of HLA-C have been reported to contribute 293 to these two kinds of differences, including promoter sequence and 294 transcription; miRNA sites in the 3’UTR sequences and RNA stability; β2m 295 association, peptide motif and peptide repertoire; TAP residency and 296 translocation to the surface [67, 71-75]. In early studies [61, 71], certain HLA-C 297 alleles were found to be present inside the cell at the same level as HLA-A and 298 
13  
HLA-B molecules but remained bound to TAP and not translocated to the cell 299 surface, similar to promiscuous chicken class I alleles. Indeed, the available data 300 from predicted or actual peptide motifs is often interpreted to show a limited 301 number of peptides that can bind HLA-C molecules compared to typical HLA-A 302 and HLA-B molecules [67, 74-76].  A more recent report [76] compares two HLA-303 C alleles, confirming that several features of the HLA-C gene contribute in a 304 complex way to cell surface expression, but finding that the peptide-binding 305 domains of one HLA-C allele which binds a greater diversity of peptides are 306 better expressed at the cell surface (at least when fused to another class I 307 molecule), the opposite as found for chicken class I molecules. How all these 308 observations fit together is at the moment unknown.   309  310 Finally, perhaps the most striking difference is that poorly-expressed 311 promiscuous alleles confer protection from Marek’s disease in chickens, while 312 well-expressed fastidious alleles are responsible for slow progression to AIDs in 313 humans. Any pretense to an overarching model must explain this difference.  314  315 Promiscuous generalists and fastidious specialists 316  317 What could be the evolutionary basis for having well-expressed fastidious and 318 poorly-expressed promiscuous class I alleles? Looking through the literature, it 319 appears that the promiscuous BF2 alleles protect chickens against a range of 320 common infectious diseases in addition to Marek’s disease [77-80]. For instance, 321 typing chickens in rural Thailand after an outbreak of avian influenza found that 322 all B21 homozygotes survived, that all chickens homozygous for the B12, B13 323 
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and B15 haplotypes with fastidious BF2 molecules died, and that in all but one 324 combination, heterozygotes with one promiscuous class I allele survived [79] 325 (Fig. 4). It appears that promiscuous BF2 molecules, wrapping up the 326 specificities of several fastidious molecules into one molecule, generally confer 327 protection to most pathogens (Fig. 2), much like a mammalian MHC haplotype 328 with multiple mammalian class I molecules. In contrast, the fastidious human 329 class I alleles HLA-B*057:01 and HLA-B*027:05 confer protection from the very 330 dangerous zoonotic pathogen HIV, which they do by binding a particular 331 protective peptide that the virus cannot change without a drastic loss of fitness 332 [13,59,81,82]. Another dangerous and possibly new pathogen, hepatitis C virus 333 (HCV) is also controlled by HLA-B*027:05 [83,84]. 334  335 Putting these two ideas together, one evolutionary hypothesis would be that 336 low-expressing promiscuous class I alleles function as generalists while the high-337 expressing fastidious alleles act as specialists [57,63]. Most of the time, the 338 generalists deal well with common pathogens, but may not always be able to 339 cope with the appearance of a new and virulent pathogen. In this case, a 340 particular fastidious molecule may present a special peptide from the new 341 pathogen, conferring protection and leading to an increase in gene frequency for 342 that allele (Fig. 5).  343  344 How does this new view stack up against the current concepts and available 345 data? The many class I alleles found in most human populations have long been 346 interpreted to mean that high levels of polymorphism are important for survival. 347 However, a population with a few generalist alleles may provide enough 348 
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protection under normal circumstances. If true, then the current view that MHC 349 typing can identify the risk of extinction for endangered species [85] may need to 350 be re-considered, to also take into account the peptide repertoire of MHC 351 molecules present in the remaining population. It is also easy to imagine that the 352 original class I alleles were promiscuous, which seems superficially similar to 353 class II molecules from which they may have arisen [6,9,86]. The major change in 354 structure-function relationships caused by rearrangement of the MHC in the 355 lineage leading to placental mammals discussed above [6,9,27] might have been 356 facilitated by a promiscuous class I allele closely-linked to promiscuous TAP 357 genes.  358  359 Fastidious alleles might arise by a few mutations from promiscuous alleles and 360 remain at a low gene frequency unless selected by a pathogen challenge, and 361 might diminish in frequency once that challenge is relaxed. However, it is also 362 possible that a selective sweep ensures near fixation of fastidious alleles. 363 Chimpanzees, which are thought to have been strongly selected during a 364 retroviral catastrophe, have two kinds of class I molecules [87-89]: those with 365 fastidious peptide motifs very similar to HLA-B*57:01 and HLA-B*27:05, and 366 those with promiscuous motifs very similar to BF2*02:01. Finally, it is important 367 to note the classification of generalist and specialist alleles may be more useful 368 for the explanation of a population response to a given pathogen than for 369 individual predictions: a promiscuous molecule may be able to protect from a 370 new and virulent pathogen (as does HLA-B*35:01 for HIV clade C but not B 371 viruses [13]), while most fastidious molecules will be unlikely to recognize a 372 protective peptide for any one particular pathogen. Having said that, a potential 373 
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advantage might arise from bundling together alleles that are promiscuous or 374 fastidious, allowing greater statistical power in genetic association studies.  375  376 Concluding remarks 377  378 The observations and hypotheses described in this review still require much 379 additional work for support and testing (see Outstanding Questions). First, 380 careful and quantitative measurement of peptide repertoire breadth, cell surface 381 expression levels and translocation to the surface for class I alleles in 382 homozygotes is required. If the broad correlations discussed here are confirmed, 383 then a comprehensive re-assessment of the extent to which (low-expressing) 384 promiscuous and (high-expressing) fastidious class I alleles confer protection to 385 various kinds of pathogens (as well as correlating with other biological and 386 medical phenomena) would be valuable.  387  388 A much deeper understanding of the mechanisms underlying the phenomena is 389 clearly required. If it is a fundamental property that leads to these correlations 390 for classical class I molecules, it is natural to ask whether the same phenomena 391 may be true for classical class II molecules. In fact, the concept of generalist and 392 specialist has already been used for class II genes in relation to nematode burden 393 of striped mice in Africa [90]. Perhaps the same idea of promiscuous and 394 fastidious recognition might be true for other (particularly innate) immune 395 receptors.   396  397 
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Finally, much can be learned from evolutionary biology approaches, including 398 observation and simulation, typically with wild outbred populations. For 399 detailed disease associations including autoimmunity and for mechanistic 400 studies, humans and mice are obviously much better suited for rapid progress 401 than chickens. However, at the least, the chicken MHC again has provided a 402 simple model to discover phenomena that have been difficult to discern, both in 403 the more complicated MHC of typical mammals and the less well-characterized 404 MHC of wild species.   405 
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Figure legends  411  412 Figure 1. The chicken MHC (BF-BL region) is much smaller and simpler than the 413 human MHC (HLA locus), with a single dominantly-expressed class I molecule 414 due to co-evolution with peptide-loading genes. Colored vertical lines or boxes 415 indicate genes, with names above; very thin vertical lines indicate regions, with 416 names above or below; location is roughly to scale, with the length of 417 approximately 100 kB indicated. Thickness of arrows pointing up indicate level 418 of expression, co-evolution between the TAP genes and the BF2 class I gene 419 indicated by a curved arrow beneath the genes. Red are genes from the class I 420 system; blue are genes from the class II system; green are genes from the class III 421 or other regions; solid colors indicate classical genes while striped colors 422 indicate genes involved in peptide loading. Figure modified from references 16 423 and 91. 424  425 Figure 2. In comparison to mammals, the MHC of chickens has strong genetic 426 associations with resistance and susceptibility to infectious diseases. Left panel. 427 A multigene family in the human MHC can encode multiple fastidious class I 428 molecules, each of which has a chance to find a protective peptide. Altogether the 429 typical human MHC haplotype confers more-or-less resistance to most 430 pathogens, a situation that reads out as a weak genetic association (since there is 431 not much difference between haplotypes). Middle panel. In contrast, the single 432 dominantly-expressed class I molecule encoded by the chicken MHC can have a 433 fastidious peptide motif that may or may not find a protective peptide from any 434 given pathogen, a situation that reads out as strong genetic associations (since 435 
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there can be enormous differences between haplotypes). Right panel. However, 436 the single dominantly-expressed class I molecule encoded by the chicken MHC 437 can have a promiscuous peptide motif, capable of binding a wide variety of 438 peptides (much like the multigene family of human class I molecules acting 439 together). Comparing two promiscuous alleles may read out as a weak genetic 440 association (since there is not much difference between them), but comparison 441 of a fastidious allele with a promiscuous allele in chickens may give strong 442 genetic associations. Figure modified extensively from reference 33. 443  444 Figure 3. The presence of a multigene family of well-expressed classical class I 445 molecules in typical placental mammals can be explained by a genomic inversion 446 that disrupted the co-evolutionary relationships between the closely-linked 447 genes of the class I system found in many other vertebrates. Top panel. The 448 genomic organization of an ancestral MHC haplotype, based on data from the 449 chicken and throughout the non-mammalian vertebrates, has class II genes in a 450 class II region, class I genes and the genes encoding antigen processing and 451 peptide-loading components in a class I region, and the class III region genes on 452 the outside. The close linkage within the class I region leads to a single 453 dominantly-expressed class I gene (red), whose peptide motif reflects the 454 specificities of the polymorphic antigen processing and peptide-loading genes 455 (all red) with which it co-evolves. Middle panel. A genomic inversion can lead to 456 the class III region moving in between the single dominantly-expressed class I 457 gene and the rest of the MHC, marooning the particular alleles of the antigen 458 processing and peptide-loading genes near the class II genes and far from the 459 class I allele that they serve. Bottom panel. The antigen processing and peptide-460 
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loading genes are selected to support any class I allele that might appear due to 461 recombination (rainbow color), which would then allow duplication within an 462 MHC haplotype to give a multigene family encoding class I molecules with 463 different peptide motifs (red, green, blue), as is found in typical mammals. 464 Regions separated by thin vertical lines; genes indicated by thicker vertical lines; 465 TAP, transporter associated with antigen presentation; LMP, inducible 466 proteasome component, originally known as low molecular weight protein; C2, 467 complement component 2; C4, complement component 4; fB, factor B. Figure 468 modified from reference 9. 469  470 Figure 4. Chicken MHC haplotypes encoding promiscuous class I molecules 471 (blue) can confer protection from a variety of viral infections under experimental 472 and field conditions, whereas MHC haplotypes encoding fastidious class I 473 molecules (red) generally confer susceptibility. Percentage of MHC genotypes in 474 a flock before and after experimental infection with Marek’s disease virus (MDV), 475 with the B2 and B21 haplotypes conferring protection (a). Percentage of Rous 476 sarcoma virus (RSV) strains that progress to give lethal tumors after 477 experimental infection, with the B6 haplotype conferring survival (b). 478 Percentage survival after natural infection with avian influenza virus (AIV) 479 under field conditions in rural Thailand, with presence of a single promiscuous 480 haplotype conferring protection, except in one combination (B2/B13) for 481 reasons that are not understood (c). Percentage of chickens ill from infectious 482 bronchitis virus (IBV) on day 10 after experimental infection, with the B2 483 haplotype conferring protection (d). Data from references 77-80. 484  485 
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Fig. 5. A model illustrates the shift in gene frequencies from a few predominant 486 generalist MHC alleles upon selection by new and/or particularly virulent 487 pathogens. The diameter of each circle indicates the frequency of a particular 488 MHC allele in a population before and after selection by a pathogen. The rainbow 489 colors indicate promiscuous molecules that act as generalists, conferring 490 protection to most pathogens including those regularly found in the 491 environment. The single colors indicate fastidious molecules encoded by genes 492 that arise by mutation and are present at low frequency, but with the possibility 493 of presenting a protective peptide from a particular pathogen. Scenarios after 494 three different pathogens are shown: one of the generalist molecules confers 495 protection to the first pathogen (top), one of the specialist molecules confers 496 protection to the second pathogen (middle), and another of the specialist 497 molecules confers protection to the third pathogen (bottom).  Figure modified 498 extensively from reference 63.  499 
23  
References 500  501 1. Klein J. 1986. The natural history of the major histocompatibility complex. 502 New York: Wiley.  503 2. Trowsdale, J. and Knight, J.C. (2013) Major histocompatibility complex 504 genomics and human disease. Annu. Rev. Genomics. Hum. Genet. 14, 301-323. 505 3. Tiercy, J.M. and Claas, F. (2013) Impact of HLA diversity on donor 506 selection in organ and stem cell transplantation. Hum. Hered 76, 178-186. 507 4. Kaufman, J. (2014) The Avian MHC. In Avian Immunology, second edition. 508 (Schat, K.A., Kaiser, P. and Kaspers, B., eds) pp. 149-167, Elsevier, Ltd. 509 5. Miller, M.M. and Taylor, R.L. (2016) Brief review of the chicken Major 510 Histocompatibility Complex: the genes, their distribution on chromosome 16, 511 and their contributions to disease resistance. Poult. Sci. 95, 375-392. 512 6. Kaufman, J. (2011) The evolutionary origins of the adaptive immune 513 system of jawed vertebrates (Chapter 3). In The Immune Response to Infection 514 (Kaufmann, S.H.E., Rouse, B.T. and Sachs, D.L., eds.) pp. 41-54, American Society 515 of Microbiology Press. 516 7. Kaufman, J. (2013) Antigen processing and presentation: evolution from a 517 bird’s eye view. Molec. Immunol. 55,159-161. 518 8. Kaufman, J. (2015) What chickens would tell you about the evolution of 519 antigen processing and presentation. Curr. Opin. Immunol. 34, 35-42. 520 9. Kaufman, J. (2018) Unfinished business: the evolution of the MHC and the 521 adaptive immune system of jawed vertebrates. Annu. Rev. Immunol., in press.  522 
24  
10. Bernatchez, L. and Landry, C. (2003) MHC studies in nonmodel 523 vertebrates: what have we learned about natural selection in 15 years? J. Evol. 524 Biol. 16, 363-377. 525 11. Spurgin, L.G. and Richardson, D.S. (2010) How pathogens drive genetic 526 diversity: MHC, mechanisms and misunderstandings. Proc. Biol. Sci. 277, 979-527 988.  528 12. Hill, A.V. (1998) The immunogenetics of human infectious diseases. Annu. 529 Rev. Immunol. 16, 593-617. 530 13. Goulder, P.J. and Walker, B.D. (2012) HIV and HLA class I: an evolving 531 relationship. Immunity 37, 426-40. 532 14. McLaren, P.J. et al. (2015) Polymorphisms of large effect explain the 533 majority of the host genetic contribution to variation of HIV-1 virus load. Proc. 534 Natl. Acad. Sci. USA 112, 14658-14663.  535 15. Briles, W.E. et al. (1983) Resistance to a malignant lymphoma in chickens 536 is mapped to subregion of major histocompatibility (B) complex. Science 219, 537 977-979.  538 16. Kaufman, J. et al. (1999) The chicken B locus is a minimal essential major 539 histocompatibility complex. Nature 401, 923-925. 540 17. Psifidi, A. et al. (2016) Genome-wide association studies of immune, 541 disease and production traits in indigenous chicken ecotypes. Genet. Sel. Evol. 542 48, 74. 543 18. Psifidi, A. et al. (2016) The genomic architecture of resistance to 544 Campylobacter jejuni intestinal colonisation in chickens. BMC Genomics. 17, 293. 545 19. Hala, K. et al. (1979) A new recombinant allele in the B complex of the 546 chicken. Folia Biol. (Praha) 25, 323-324. 547 
25  
20. Koch, C. et al. (1983) New recombinants within the MHC (B-complex) of 548 the chicken. Tissue Antigens 21, 129-137. 549 21. Skjødt, K. et al (1988) Analysis of chickens for recombination within the 550 MHC (B-complex). Tissue Antigens, 1985, 25: 278-282. 551 22. Hala, K. et al. (1988) Attempt to detect recombination between B-F and B-552 L genes within the chicken B complex by serological typing, in vitro MLR, and 553 RFLP analyses. Immunogenetics 28, 433-438. 554 23. Simonsen, M. et al. (1982) The MHC haplotypes of the chicken. 555 Immunogenetics 16, 513-532. 556 24. Hosomichi, K. et al. (2008) Contribution of mutation, recombination, and 557 gene conversion to chicken MHC-B haplotype diversity. J. Immunol. 181, 3393-558 3399. 559 25. Fulton, J.E. et al. (2016) A high-density SNP panel reveals extensive 560 diversity, frequent recombination and multiple recombination hotspots within 561 the chicken major histocompatibility complex B region between BG2 and CD1A1. 562 Genet. Sel. Evol. 48:1. 563 26. van Hateren, A. et al. (2013) A mechanistic basis for the co-evolution of 564 chicken tapasin and major histocompatibility complex class I (MHC I) proteins. J. 565 Biol. Chem. 288, 32797-32808. 566 27. Walker, B.A. et al.  (2011) The dominantly expressed class I molecule of 567 the chicken MHC is explained by coevolution with the polymorphic peptide 568 transporter (TAP) genes. Proc. Natl. Acad. Sci. USA 108, 8396-8401. 569 28. Chazara, O. et al. (2011) Organisation and diversity of the class II DM 570 region of the chicken MHC. Mol. Immunol. 48, 1263-1271. 571 
26  
29. Salomonsen, J. et al. (2003) The properties of the single chicken MHC 572 classical class II alpha chain (B-LA) gene indicate an ancient origin for the DR/E-573 like isotype of class II molecules. Immunogenetics 55, 605-614. 574 30. Riegert, P et al. (1996) The chicken beta2-microglobulin gene is located 575 on a non-major histocompatibility complex microchromosome: a small, G+C-rich 576 gene with X and Y boxes in the promoter. Proc. Natl. Acad. Sc.i USA. 93, 1243-577 1248. 578 31. Jones, C.T. et al. (1997) Gene homologs on human chromosome 15q21-579 q26 and a chicken microchromosome identify a new conserved segment. Mamm. 580 Genome. 8, 436-440. 581 32. Erath, S. and Groettrup, M. (2015) No evidence for immunoproteasomes 582 in chicken lymphoid organs and activated lymphocytes. Immunogenetics 67, 51-583 60. 584 33. Kaufman, J. et al.  (1995) A "minimal essential Mhc" and an "unrecognized 585 Mhc": two extremes in selection for polymorphism. Immunol. Rev. 143: 63-88. 586 34. Kaufman, J. (2015) Co-evolution with chicken class I genes. Immunol. Rev. 587 267, 56-71. 588 35. Tregaskes, C.A. et al. (2016) Surface expression, peptide repertoire, and 589 thermostability of chicken class I molecules correlate with peptide transporter 590 specificity. Proc. Natl. Acad. Sci. USA 113, 692-697. 591 36. Shaw, I. et al (2007) Different evolutionary histories of the two classical 592 class I genes BF1 and BF2 illustrate drift and selection within the stable MHC 593 haplotypes of chickens. J. Immunol. 178, 5744-5752. 594 
27  
37. Wallny, H.J. et al. (2006) Peptide motifs of the single dominantly 595 expressed class I molecule explain the striking MHC-determined response to 596 Rous sarcoma virus in chickens. Proc. Natl. Acad. Sci. USA 103, 1434-1439. 597 38. Koch, M. et al. (2007) Structures of an MHC class I molecule from B21 598 chickens illustrate promiscuous peptide binding. Immunity 27, 885-899. 599 39. Butter, C. et al. (2013) The peptide motif of the single dominantly 600 expressed class I molecule of the chicken MHC can explain the response to a 601 molecular defined vaccine of infectious bursal disease virus (IBDV). 602 Immunogenetics 65, 609-618. 603 40. MHC Sequencing Consortium (1999) Complete sequence and gene map of 604 a human major histocompatibility complex. Nature 401, 921–923. 605 41. Carrington, M. (1999) Recombination within the human MHC. Immunol 606 Rev 167, 245–256. 607 42. Momburg, F. et al. (1994) Selectivity of MHC-encoded peptide 608 transporters from human, mouse and rat. Nature 367,648–651. 609 43. Obst, R. et al. (1995) TAP polymorphism does not influence transport of 610 peptide variants in mice and humans. Eur. J. Immunol. 25, 2170–2176. 611 44. Williams, A.P. et al (2000) Identification of novel Tapasin polymorphisms 612 and linkage disequilibrium to MHC class I alleles. Immunogenetics 52, 9-11. 613 45. Joly, E. et al. (1998) Co-evolution of rat TAP transporters and MHC class I 614 RT1-A molecules. Curr. Biol. 8, 169-172. 615 46. Kaufman, J. (1999) Co-evolving genes in MHC haplotypes: the "rule" for 616 nonmammalian vertebrates? Immunogenetics 50, 228-236. 617 47. Moon, D.A. et al. (2005) The MHC of the duck (Anas platyrhynchos) 618 contains five differentially expressed class I genes. J. Immunol.175, 6702-6712.  619 
28  
48. Mesa, C.M. et al. (2004) The dominant MHC class I gene is adjacent to the 620 polymorphic TAP2 gene in the duck, Anas platyrhynchos. Immunogenetics 56, 621 192-203. 622 49. Ohta, Y. et al. (2006) Ancestral organization of the MHC revealed in the 623 amphibian Xenopus. J. Immunol. 176, 3674-3685. 624 50. Lukacs, M.F. et al. (2007) Genomic organization of duplicated major 625 histocompatibility complex class I regions in Atlantic salmon (Salmo salar). BMC 626 Genomics 8, 251. 627 51. Grimholt, U. et al. (2003) MHC polymorphism and disease resistance in 628 Atlantic salmon (Salmo salar); facing pathogens with single expressed major 629 histocompatibility class I and class II loci. Immunogenetics 55, 210-219. 630 52. Rogers, S.L. et al. (2005) Characterization of the chicken C-type lectin-like 631 receptors B-NK and B-lec suggests that the NK complex and the MHC share a 632 common ancestral region. J. Immunol. 174, 3475-3483. 633 53. Belov, K. et al. (2006) Reconstructing an ancestral mammalian immune 634 supercomplex from a marsupial major histocompatibility complex. PLoS Biol. 4, 635 e46 636 54. Osterrieder, N. et al. (2006) Marek's disease virus: from miasma to model. 637 Nat. Rev. Microbiol. 4, 283-294. 638 55. Plachy, J. et al. (1992) Biology of the chicken MHC (B complex). Crit. Rev. 639 Immunol. 12, 47-79. 640 56. Zhang, J. et al. (2012) Narrow groove and restricted anchors of MHC class 641 I molecule BF2*0401 plus peptide transporter restriction can explain disease 642 susceptibility of B4 chickens. J. Immunol. 189, 4478-4487. 643 
29  
57. Chappell, P. et al. (2015) Expression levels of MHC class I molecules are 644 inversely correlated with promiscuity of peptide binding. eLIFE 4, 05345. 645 58. Mwangi, W.N. et al. (2011). Clonal structure of rapid-onset MDV-driven 646 CD4+ lymphomas and responding CD8+ T cells. PLoS Pathog. 7, e1001337. 647 59. Kosmrlj, A. et al. (2010) Effects of thymic selection of the T-cell repertoire 648 on HLA class I-associated control of HIV infection. Nature 465: 350-354. 649 60. Paul, S. et al. (2013) HLA class I alleles are associated with peptide-650 binding repertoires of different size, affinity, and immunogenicity. J. Immunol. 651 191, 5831-5839. 652 61. Neisig, A. et al. (1996) Allele-specific differences in the interaction of MHC 653 class I molecules with transporters associated with antigen processing. J. 654 Immunol. 156, 3196-206.  655 62. Rizvi, S.M. et al. (2014) Distinct assembly profiles of HLA-B molecules. J. 656 Immunol. 192, 4967-4976.  657 63. Kaufman, J. (2017) A New View of How MHC Class I Molecules Fight 658 Disease: Generalists and Specialists. In: Evolutionary Biology: Self/Nonself 659 Evolution, Species and Complex Traits Evolution, Methods and Concepts. Pierre 660 Pontarotti, editor. Springer, Switzerland.  661 64. Madden, D.R. et al. (1993) The antigenic identity of peptide-MHC complexes: 662 a comparison of the conformations of five viral peptides presented by HLA-A2. 663 Cell 75, 693-708. 664 65. Chen, K.Y. et al. (2012) Structural and functional distinctiveness of HLA-A2 665 allelic variants. Immunol. Res. 53, 182-190. 666 66. Illing, P.T. et al. (2012) Immune self-reactivity triggered by drug-modified 667 HLA-peptide repertoire. Nature 486, 554-558. 668 
30  
67. Blais, M.E. et al. (2011) HLA-C as a mediator of natural killer and T-cell 669 activation: spectator or key player? Immunology 133, 1-7. 670 68. Thomas, R. et al. (2009) HLA-C cell surface expression and control of 671 HIV/AIDS correlate with a variant upstream of HLA-C. Nat. Genet. 41, 1290-1294.  672 69. Apps, R. et al. (2013) Influence of HLA-C expression level on HIV control. 673 Science 340, 87-91.  674 70. McLaren, P.J. et al. (2015) Polymorphisms of large effect explain the majority 675 of the host genetic contribution to variation of HIV-1 virus load. Proc. Natl. Acad. 676 Sci. U S A. 112, 14658-14663.  677 71. Neisig, A. et al. (1998) Reduced cell surface expression of HLA-C molecules 678 correlates with restricted peptide binding and stable TAP interaction. J. 679 Immunol. 160, 171-9. 680 72. Kulkarni, S. et al. (2011) Differential microRNA regulation of HLA-C 681 expression and its association with HIV control. Nature 472, 495-498. 682 73. Vince, N. et al. (2016) HLA-C level is regulated by a polymorphic Oct1 binding 683 site in the HLA-C promoter region. Am. J. Hum. Genet. 99, 1353-1358. 684 74. Falk, K. et al. (1993) Allele-specific peptide ligand motifs of HLA-C molecules. 685 Proc. Natl. Acad. Sci. U S A. 90, 12005-9. 686 75. Rasmussen, M. et al. (2014) Uncovering the peptide-binding specificities 687 of HLA-C: a general strategy to determine the specificity of any MHC class I 688 molecule. J. Immunol. 193, 4790-4802.  689 76. Kaur, G. et al. 2017. Structural and regulatory diversity shape HLA-C 690 protein expression levels. Nat. Commun. 8, 15924.  691 
31  
77. Simonsen, M. (1987) The MHC of the chicken, genomic structure, gene 692 products, and resistance to oncogenic DNA and RNA viruses. Vet. Immunol. 693 Immunopathol. 17, 243-53. 694 78. McBride, R.A. et al. (1981) MHC gene control of growth of avian sarcoma 695 virus-induced tumours in chickens: a study on the role of virus strains. J. 696 Immunogenet. 8, 207-214. 697 79. Boonyanuwat, K. et al. (2006) Influences of major histocompatibility complex 698 class I haplotypes on avian influenza virus disease traits in Thai indigenous 699 chickens. Anim. Sci. J. 77, 285–289  700 80. Banat, G.R. et al. (2013) Association of the chicken MHC B haplotypes with 701 resistance to avian coronavirus. Dev. Comp. Immunol. 39, 430-437. 702 81. Brennan, C.A. et al. (2012) Early HLA-B*57-restricted CD8+ T lymphocyte 703 responses predict HIV-1 disease progression. J. Virol. 86, 10505-10516. 704 82. Schneidewind, A. et al. (2007) Escape from the dominant HLA-B27-restricted 705 cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction 706 in human immunodeficiency virus type 1 replication. J. Virol. 81, 12382-12393. 707 83. Pybus, O.G. and Thézé, J. (2016) Hepacivirus cross-species transmission and 708 the origins of the hepatitis C virus. Curr. Opin. Virol. 16, 1-7. 709 84. Dazert, E. et al. (2009) Loss of viral fitness and cross-recognition by CD8+ T 710 cells limit HCV escape from a protective HLA-B27-restricted human immune 711 response. J. Clin. Invest. 119, 376-386. 712 85. Sommer, S. (2005) The importance of immune gene variability (MHC) in 713 evolutionary ecology and conservation. Frontiers in Zoology 2, 16. 714 86. Kaufman, J.F. et al.  (1984) The class II molecules of the human and murine 715 major histocompatibility complex. Cell 36, 1-13. 716 
32  
87. de Groot, N.G. et al. (2002) Evidence for an ancient selective sweep in the 717 MHC class I gene repertoire of chimpanzees. Proc. Natl. Acad. Sci. U S A. 99, 718 11748-11753. 719 88. Sidney, J. et al. (2006) Detailed characterization of the peptide binding 720 specificity of five common Patr class I MHC molecules. Immunogenetics 58, 559–721 570. 722 89. de Groot, N.G. et al. (2010) AIDS-protective HLA-B*27/B*57 and chimpanzee 723 MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz. Proc 724 Natl Acad Sci U S A. 107, 15175–15180. 725 90. Froeschke, G. and Sommer, S. (2012) Insights into the complex associations 726 between MHC class II DRB polymorphism and multiple gastrointestinal parasite 727 infestations in the striped mouse. PLoS ONE 7, e31820. 728 91. Kaufman, J. (2016) “Genetics and genomic organisation of the major 729 histocompatibility complex (MHC) with infectious disease”. In: Encyclopedia of 730 
Immunobiology, vol. 2 (Ratcliffe, M.J.H., editor-in-chief) pp. 166-173, Academic 731 Press, Oxford. 732 
Trends Box (900 characters and spaces, 3-5 bullet points on recent developments)  
• A broad overview of classical MHC I expression and bound peptides reveals an inverse correlation between repertoire breadth and cell surface expression in some chicken and human alleles  
• Several chicken class I alleles with wide peptide binding repertoire (promiscuity) are associated with resistance to a variety of common diseases   
• Conversely, narrow peptide binding repertoire (fastidiousness) in some human HLA-B alleles is associated with resistance to HIV progression   
• Cell surface expression of some classical class I alleles depends on the regulation of translocation to the cell surface rather than of translation. MHC translocation is influenced by peptide-translocation in chickens and by tapasin interaction in humans       
Comment [DJ(1]: Our style is generally to write these as full sentences, please review the changes below. 
Outstanding questions (2000 characters and spaces in bullet points)  
• To what extent is the inverse correlation between cell surface expression and peptide repertoire found for all classical class I molecules in chickens and humans? Is it a true hierarchy or just two groups? If this is not the case for human HLA-C, why?   What is the mechanism for the inverse correlation between cell surface expression and peptide repertoire found for classical class I molecules? Is it due to intrinsic differences in folding of the class I molecule, efficiency of interactions the peptide loading complex, quality control steps (like TAPBPR/UGT), or other important steps of translocation? In addition to these biochemical mechanisms, what are the selective pressures for the inverse correlation between cell surface expression and peptide repertoire found for classical class I molecules (e.g. optimization of T cell repertoire, avoidance of auto-immunity)?   
• To what extent does the low expression level/peptide promiscuity really correlate with resistance to common pathogens? How is this correlation influenced by the type of pathogen involved (e.g. virus with a small or large genome, for which the number of potential protective peptides is different), and what is the underlying mechanism for protection (number of T cells activated, higher probability to bind a given efficacious peptide)?  
• Similarly, what are the mechanisms underlying protection against a given zoonosis by high expression level/fastidious peptide binding MHCs?  Is the binding of special protective peptides that are critical for viral fitness always involved?  
• To what extent is this new view true for a wide variety of species? These studies should be easier in mice and primates where significant literature is available, but are largely relevant across the animal kingdom (e.g.  farm and sport animals,  farmed fish).   
• To what extent are these features found for classical class II molecules?   
Comment [DJ(1]: The questions were reworded and shortened to fit within the character limit. Please review this version. Thank you. 
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